Amgen Reportable Segment — Other segment items decreased by 404.6% to -$1.64B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.1%, from -$1.66B to -$1.64B.
amgn_segment_reportable_segment_other_segment_items| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $520.00M | $445.00M | -$1.66B | -$573.00M | $539.00M | -$1.64B |
| QoQ Change | — | -14.4% | -473.3% | +65.5% | +194.1% | -404.6% |
| YoY Change | — | — | — | -210.2% | +21.1% | +1.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.